About this trial
Patients will undergo quantitative perfusion assessment in cardiovascular magnetic resonance imaging (dual bolus or dual sequence approach) as well as invasive coronary angiography for assessment of fractional flow reserve (FFR) including assessment of coronary flow reserve (CFR) and microcirculatory resistance (IMR).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
clinical indication for vasodilatator CMR or invasive coronar angiography
capability to give informed consent
Disqualifiers
general: non-compliance, <18 years of age, pregnancy
contraindications for CMR (non-CMR compatible device, chronic kidney disease (eGFR <30ml/min), allergies (medications)
Trial population
All patients referred to the clinical service for ischaemia evaluation
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Quantitative Perfusion
Correlation of myocardial blood flow and perfusion reserve in CMR with invasively dervived fractional flow reserve (FFR), coronary flow reserve (CFR) and microcirculatory resistance (IMR)
Dual bolus vs dual sequence
Compare both CMR-derived quantitative perfusion for prediction of FFR/CFR/IMR
Secondary outcomes
Strain
Correlation of segmental perfusion and myocardial strain
Tissue characterisation
Correlation of segmental perfusion and T1/T2/ECV/LGE
Cardiovascular Hospitalisation (CVH)
CVH within 12 months
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: